Cargando…
Long Non-Coding RNA BCAR4 Promotes Growth, Invasion and Tumorigenicity by Targeting miR-2276 to Upregulate MMP7 Expression in Glioma
OBJECTIVE: Long non-coding RNA breast cancer anti-estrogen resistance 4 (BCAR4) has been recognized as a proto-oncogene in various malignancies. It has been reported to be highly expressed and promote cell proliferation in glioma. However, its additional roles in gliomagenesis remain largely unclear...
Autores principales: | Wang, Zhifeng, Wang, Longlong, Liang, Zan, Xi, Yanguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913310/ https://www.ncbi.nlm.nih.gov/pubmed/31849498 http://dx.doi.org/10.2147/OTT.S226026 |
Ejemplares similares
-
Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma
por: Sun, Jingxian, et al.
Publicado: (2021) -
LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer
por: Ouyang, Shurui, et al.
Publicado: (2019) -
A fusion of CD63–BCAR4 identified in lung adenocarcinoma promotes tumorigenicity and metastasis
por: Bae, Kieun, et al.
Publicado: (2020) -
LncRNA BCAR4 promotes liver cancer progression by upregulating ANAPC11 expression through sponging miR-1261
por: Zhang, Yu, et al.
Publicado: (2020) -
Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer
por: Wang, Xiaojing, et al.
Publicado: (2020)